BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Mats Lundgren has more than 25 years of experience in vaccinology. After earning his PhD in Immunology, Cell, and Molecular Biology from the Karolinska Institute in Sweden, Dr. Lundgren completed post-doctoral training at the MRC Clinical Sciences Centre, Imperial College School of Medicine in the United Kingdom. In his industrial career Mats has held positions at the bench and in management at Pharmacia (now part of GE Healthcare’s Life Sciences business), AstraZeneca, and several smaller biotechnology companies. Prior to joining GE as a Research and Development scientist, Dr. Lundgren managed both the cell line and upstream process development teams at AstraZeneca. In his current role as Customer Applications Director at GE, Mats helps companies to implement modern processes with the goal of achieving more efficient production and higher vaccine quality.